Abstract:Ever since the discovery of its neurite growth promoting activity in sympathetic and sensory ganglia, nerve growth factor (NGF) became the prototype of the large family of neurotrophins. The use of primary cultures and clonal cell lines has revealed several distinct actions of NGF and other neurotrophins. Among several models of NGF activity, the clonal cell line PC12 is the most widely employed. Thus, in the presence of NGF, through the activation of the transmembrane protein TrkA, these cells undergo a progressive mitotic arrest and start to grow electrically excitable neuritis. A vast number of studies opened intriguing aspects of NGF mechanisms of action, its biological properties, and potential use as therapeutic agents. In this context, identifying and utilizing small portions of NGF is of great interest and involves several human diseases including Alzheimer's disease. Here we report the specific action of the peptide encompassing the 1-14 sequence of the human NGF (NGF(1-14)), identified on the basis of scattered indications present in literature. The biological activity of NGF(1-14) was tested on PC12 cells, and its binding with TrkA was predicted by means of a computational approach. NGF(1-14) does not elicit the neurite outgrowth promoting activity, typical of the whole protein, and it only has a moderate action on PC12 proliferation. However, this peptide exerts, in a dose and time dependent fashion, an effective and specific NGF-like action on some highly conserved and biologically crucial intermediates of its intracellular targets such as Akt and CREB. These findings indicate that not all TrkA pathways must be at all times operative, and open the possibility of testing each of them in relation with specific NGF needs, biological actions, and potential therapeutic use.

Nerve Growth Factor Receptor TrkA Exists As a Preformed, Yet Inactive, Dimer in Living Cells

The Nerve Growth Factor Receptor TrkA Exists As a Pre‐formed Homodimer Before Ligand Binding

Brain-derived Neurotrophic Factor Receptor TrkB Exists As a Preformed Dimer in Living Cells

Transactivation of Trk Neurotrophin Receptors by G-Protein-Coupled Receptor Ligands Occurs on Intracellular Membranes

Disentangling the signaling complexity of nerve growth factor receptors by CRISPR/Cas9

Molecular Characterization of the TrkA/NGF Receptor Minimal Enhancer Reveals Regulation by Multiple Cis Elements to Drive Embryonic Neuron Expression.

Extracellular Juxtamembrane Motif Critical for TrkB Preformed Dimer and Activation

Simulation of neurotrophin receptor transmembrane helix interactions reveals active states and distinct signaling mechanisms

Activation of neurotrophin signalling with light‐inducible receptor tyrosine kinases

TrkA in vivo function is negatively regulated by ubiquitination.

TrkA Undergoes a Tetramer-to-dimer Conversion to Open TrkH Which Enables Changes in Membrane Potential.

Nerve Growth Factor Signaling from Membrane Microdomains to the Nucleus: Differential Regulation by Caveolins.

Modifications in the C-terminal tail of TrkC significantly alter neurotrophin-3-promoted outgrowth of neurite-like processes from PC12 cells

A novel endocytic recycling signal distinguishes biological responses of Trk neurotrophin receptors.

The p75 Neurotrophin Receptor Facilitates TrkB Signaling and Function in Rat Hippocampal Neurons

Atypical cellular responses mediated by intracellular constitutive active TrkB (NTRK2) kinase domains and a solely intracellular NTRK2-fusion oncogene

A small linear peptide encompassing the NGF N-terminus partly mimics the biological activities of the entire neurotrophin in PC12 cells

Conformational Transitions of a Neurotensin Receptor 1–G I1 Complex

Regulation of Low Affinity Neurotrophin Receptor (p75(ntr)) by Early Growth Response (egr) Transcriptional Regulators.

Mechanisms of Activation of Receptor Tyrosine Kinases: Monomers or Dimers

Cell Survival through Trk Neurotrophin Receptors Is Differentially Regulated by Ubiquitination